NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $34.1 million in its first quarter.
The Newton, Massachusetts-based company said it had a loss of 30 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.
The pharmaceutical company posted revenue of $38.7 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $37.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
